• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Google

LifeMine Therapeutics combines AI, drug discovery & microbes with $55m launch

September 18, 2017 By Sarah Faulkner

microbe

Backed by the likes of Google and Merck (NYSE:MRK), Cambridge, Mass.-based LifeMine Therapeutics launched today by closing a $55 million Series A round. The company calls itself the first to “massively scale the genomic discovery of powerful new drugs from eukaryotic microbes”. LifeMine plans to use artificial intelligence to hunt down drugs hidden within the DNA […]

Filed Under: Discovery, Featured, Funding Roundup, Pharmaceuticals, Wall Street Beat Tagged With: Google, lifeminetherapeutics, Merck

Google backs Decibel Therapeutics in big data hearing loss play

July 6, 2017 By Sarah Faulkner

Decibel Therapeutics

Decibel Therapeutics said today it landed an investment from GV, formerly Google Ventures. GV agreed to make an equity investment in the Boston-based company and lend its capabilities in big data sciences and analytics to Decibel’s efforts in developing therapies for hearing loss and tinnitus. “We are delighted to work with GV to amplify our […]

Filed Under: Big Data, Discovery, Featured, Funding Roundup, Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Research & Development Tagged With: decibeltherapeutics, Google

Verily launches biosensor-equipped Study Watch for clinical study patient monitoring

April 17, 2017 By Fink Densford

Verily's Study Watch

Verily Life Sciences, the medical arm of Google parent Alphabet (NSDQ:GOOGL), today unveiled its Study Watch, a wearable device designed to passively capture health data. The watch, intended to create a method of unobtrusive biosensing, is equipped with multiple sensors, including an electrocardiogram, and can monitor heart rate, electrodermal activity and inertial movements, with a battery life of up […]

Filed Under: Business/Financial News, Clinical Trials, Patient Monitoring Tagged With: Google, Verily

This contact lenses breakthrough could enable glucose monitoring

April 4, 2017 By Danielle Kirsh

Biosensing contact lenses may not be able to self-heal like “The Terminator,” but they could measure blood glucose and detect other signs of disease in the future. Oregon State University researchers are set to present a study that suggests transparent biosensors that are embedded into contact lenses could provide insight for doctors and patients without […]

Filed Under: Diabetes, Featured Tagged With: biosensors, contact lenses, Diabetes, Google, medtech, Novartis

How virtual and mixed reality are changing drug delivery and device design

February 17, 2017 By Sarah Faulkner

How virtual and mixed reality is changing drug delivery and device design

Kai Worrell believes that virtual and mixed reality may change the way companies design medical devices, and he’s putting that idea into practice. “We think it’s going to transform the way we do feasibility testing and cognitive walk-through simulations,” he said. “We think it’s going to help us understand the cognition of our users, clinical […]

Filed Under: Drug-Device Combinations, Featured, Research & Development Tagged With: Boston Scientific, Facebook, Google, johnsonandjohnson, Medtronic, Samsung, Worrell

Sunovion, Novartis ink licensing deal for inhaled COPD drugs

December 22, 2016 By Sarah Faulkner

Novartis

Novartis (NYSE:NVS) said today that it out-licensed its U.S. commercial rights for 3 chronic obstructive pulmonary disease drugs to Sunovion Pharmaceuticals. Novartis will commercialize the Utibron Neohaler, Seebri Neohaler, and Arcapta Neohaler inhalation powders outside of the U.S. The Switzerland-based company will manufacture the inhaled powders for Sunovion, according to the agreement. “Given the evolving market […]

Filed Under: Distribution, Featured, Respiratory, Wall Street Beat Tagged With: Google, Novartis, Sunovion Pharmaceuticals

Novartis backs off from 2016 date for testing Google autofocus lens

November 21, 2016 By Sarah Faulkner

Novartis eyes Alcon sale

Novartis (NYSE:NVS) is reportedly backing off a 2016 start date to test its autofocusing contact lens in clinical trials, but it told Reuters that the product is “progressing steadily” in its collaboration with Google (NSDQ:GOOGL). In 2014, CEO Joe Jimenez said he hoped the lens would be on the market in 5 years and last year he said his […]

Filed Under: Clinical Trials, Featured, Optical/Ophthalmic, Research & Development Tagged With: Google, Novartis

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS